Recent Federal Circuit rulings strengthen obviousness-type double patenting defense to assertions of patent infringement in pharmaceutical litigations.Published in:Journal of Generic Medicines, 2011, v. 8, n. 2, p. 111, doi. 10.1177/1741134311408777By:Pejic, P BrankoPublication type:Article
OBVIOUSNESS-TYPE DOUBLE PATENTING - A SURPRISING IMPEDIMENT TO COLLABORATIVE RESEARCH AND DEVELOPMENT.Published in:Business Law Review (15337421), 2013, v. 46, p. 63By:SILVERSTEIN, DAVIDPublication type:Article
OBVIOUSNESS-TYPE DOUBLE PATENTING:WHY IT EXISTS AND WHEN IT APPLIES.Published in:Akron Law Review, 2019, v. 53, n. 4, p. 1017By:Kazhdan, DanielPublication type:Article